Vicente Lim
Psychiatry · Roselle, NJNPI 1275529356
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 958 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 958 payments — averaging $14.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$2K
- Neurocrine Biosciences, Inc.$2K
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Alkermes, Inc.$1K
- plus $4K from 8 others
What the payments were for
- Food & beverage$13,24098%
- Education$2602%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 143 | $2,421 |
| Neurocrine Biosciences, Inc. | 136 | $1,896 |
| AbbVie(2 entities) | 135 | $1,423 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 93 | $1,321 |
| Otsuka America Pharmaceutical, Inc. | 99 | $1,240 |
| Alkermes, Inc. | 75 | $1,100 |
| Sunovion Pharmaceuticals Inc. | 52 | $968 |
| Johnson & Johnson | 66 | $966 |
| Lundbeck LLC | 52 | $723 |
| Vanda Pharmaceuticals Inc. | 39 | $530 |
| Indivior Inc. | 37 | $525 |
| Luye Pharma (USA) Ltd. | 14 | $191 |
| E.r. Squibb & Sons, L.L.C. | 16 | $181 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$13,500 in reported general payments places this provider in the 95th percentile of 1,119 psychiatry providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 400 | $1,314,480 |
| AustedoDeutetrabenazine | 176 | $942,096 |
| IngrezzaValbenazine Tosylate | 104 | $907,285 |
| Abilify MaintenaAripiprazole | 107 | $353,900 |
| AristadaAripiprazole Lauroxil | 76 | $301,653 |
| VivitrolNaltrexone Microspheres | 132 | $271,308 |
| Austedo XrDeutetrabenazine | 40 | $260,041 |
| LybalviOlanzapine/Samidorphan Malate | 129 | $258,969 |
| VraylarCariprazine Hcl | 152 | $258,171 |
| Invega TrinzaPaliperidone Palmitate | 24 | $200,056 |
| JubliaEfinaconazole | 36 | $106,681 |
| PerserisRisperidone | 38 | $96,619 |
| LatudaLurasidone Hcl | 37 | $90,372 |
| Risperdal ConstaRisperidone Microspheres | 32 | $79,128 |
| CaplytaLumateperone Tosylate | 43 | $78,901 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta | $966 | $1,593,665456 claims |
| Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr, Uzedy | $2,421 | $1,275,289258 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $1,896 | $907,285104 claims |
| Alkermes, Inc.Aristada, Vivitrol, Lybalvi, Aristada Initio | $1,100 | $856,808348 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $1,240 | $432,072142 claims |
| AbbVieVraylar | $1,423 | $258,171152 claims |
| Indivior Inc.Perseris | $525 | $96,61938 claims |
| Sunovion Pharmaceuticals Inc.Latuda | $968 | $90,37237 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,321 | $78,90143 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,119 psychiatry providers in New Jersey.
Other psychiatry in Roselle
- Marc CantillonLivingston$522K
- Robert BransfieldRed Bank$415K
- Erika ConcepcionLong Branch$354K
- Leon RosenbergCherry Hill$257K
- Lloyd AlceraMarlton$187K
- Gary SmallHackensack$170K
- Shankar SrinivasanParsippany$155K
- Matthew PiteraToms River$153K
- Boris BorodulinEast Brunswick$116K
- Anthony RostainCamden$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.